Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Growth

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 24.8938.4919.51365.23-83.70

What is the latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE is 24.89 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202624.89
Mar202538.49
Mar202419.51
Mar2023365.23
Mar2022-83.70

How is Core EBITDA Growth of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Growth % Change
Mar2026 24.89
-35.33
Mar2025 38.49
97.28
Mar2024 19.51
-94.66
Mar2023 365.23
Positive
Mar2022 -83.7 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Growth ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹9,146.7 Cr 2.5% -4.7% 9.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr -1.2% -2.2% 15.8% Stock Analytics
DIVIS LABORATORIES ₹227,958.0 Cr 1% 16.3% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,990.0 Cr 3.2% -0.8% 38.6% Stock Analytics
CIPLA ₹116,141.0 Cr -0.9% 1.6% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,604.4 Cr -1.7% -0.1% -6.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

2.5%

-4.7%

9.9%

SENSEX

-0.7%

0.1%

-3.4%


You may also like the below Video Courses